Drugs Made In America Acquisition (DMIIR) Operating Income (2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Operating Income came in at -$235472.0 in Q4 2025, down 51.42% on a QoQ basis from -$155513.0 in Q3 2025.
Drugs Made In America Acquisition (DMIIR) Operating Income (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 1 years of Operating Income data on file, last reported at -$235472.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | -427,850.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | -612,993.00 |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | -482,100.00 |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | -84,204.00 |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | -201,744.00 |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | -165,444.00 |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | -218,386.00 |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | -196,464.00 |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | -198,194.00 |
| 10 | Drugs Made In America Acquisition | - | - | - | -235,472.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -235,472.00 |
| Sep 30, 2025 | -155,513.00 |